Cellectis
CLLS
#7214
Rank
S$0.63 B
Marketcap
S$6.09
Share price
-1.05%
Change (1 day)
131.53%
Change (1 year)

Cellectis (CLLS) Fails to deliver data

Key failure to deliver metrics for Cellectis:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Cellectis (CLLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Cellectis (CLLS) - since 2015

Volume in USD (price x number of shares), data since 2015

Cellectis (CLLS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025S$0.29 M-67.12%
2024S$0.9 M-64.26%
2023S$2.53 M-35.43%
2022S$3.92 M-74.81%
2021S$15.59 M-26.71%
2020S$21.27 M2750.05%
2019S$0.74 M-93.48%
2018S$11.44 M85.32%
2017S$6.17 M-25.24%
2016S$8.26 M-76.95%
2015S$35.83 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
uniQure
QURE
S$25.29 MS$36.91 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
S$15.95 MS$65.06 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$5.36 MS$70.47 M๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
S$0.53 MS$0.54 M๐Ÿ‡บ๐Ÿ‡ธ USA